What this evidence supports
ARPA-H ADVOCATE is explicitly targeting clinically consequential agentic AI with supervisory monitoring.
What it does not establish
Program objectives are prospective and do not establish that such systems are yet clinically validated or FDA authorized.
Record details
- Source authority
- ARPA-H
- Evidence level
- E5
- Directness
- 5/5
- Recency
- 4/5
- Decision relevance
- 5/5
- Date
- 2026-01-13
Primary source
Related intelligence
ARPA-H ADVOCATE targets FDA-authorized clinical agentic AI for cardiovascular care